Cannapharmarx Inc Quick Ratio (CPMD) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Cannapharmarx Inc   (CPMD)

Cannapharmarx Inc 's Quick Ratio

CPMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0 a new company low.

Within Major Pharmaceutical Preparations industry 457 other companies have achieved higher Quick Ratio than Cannapharmarx Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 0 to 4548.

Explain Quick Ratio?
How much Cash & cash equivalents CPMD´s has?
What are CPMD´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPMD Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -58.14 % 17.08 % -32.09 % 26.56 % 27.28 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 0 - - - -
CPMD's Total Ranking # 4548 # 0 # 0 # 0 # 0
Seq. Current Liabilities Change -61.51 % 8.63 % 1.77 % -1.64 % 7.67 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 458
Healthcare Sector # 932
Overall Market # 4548


Quick Ratio Statistics
High Average Low
1.48 0.18 0
(Jun 30 2015)   (Dec 31 2023)




Financial Statements
Cannapharmarx Inc 's Current Liabilities $ 12 Millions Visit CPMD's Balance sheet
Cannapharmarx Inc 's Cash & cash equivalent $ 0 Millions Visit CPMD's Balance sheet
Source of CPMD's Sales Visit CPMD's Sales by Geography


Cumulative Cannapharmarx Inc 's Quick Ratio

CPMD's Quick Ratio for the trailling 12 Months

CPMD Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -16.49 % 2.69 % -3.3 % 22.46 % 19.32 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0 - - - -
Total Ranking TTM # 4203
Seq. Current Liabilities TTM Growth -14.28 % 4.05 % -10.78 % 4.94 % 5.41 %
Seq. Cash & cash equivalent TTM Growth - - - - -

Quick ratio ranking by company, industry and sector >> Back to CPMD Financial Strength Comparisons >> Go to Compare CPMD Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CPMD's Current Liabilities to $12.12 millions, cumulative Quick Ratio